Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
163.21
+0.41 (0.25%)
At close: Aug 17, 2026, 4:00 PM EDT
163.21
0.00 (0.00%)
After-hours: Aug 17, 2026, 5:33 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.42 billion as of August 17, 2026. Its market cap has increased by 193.49% in one year.
Market Cap
6.42B
Enterprise Value
5.87B
1-Year Change
193.49%
Ranking
Category
Stock Price
$163.21
ChartMarket Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.42B, an increase of 4,341.16%. That is a compound annual growth rate of 141.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 6.42B | 7.00% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 6.91B |
| CG Oncology | 6.65B |
| Cogent Biosciences | 6.58B |
| Mirum Pharmaceuticals | 6.53B |
| Dianthus Therapeutics | 6.49B |
| Erasca | 6.43B |
| Scholar Rock Holding | 6.40B |
| Caris Life Sciences | 6.16B |